Developing computer-aided detection for lung and colon images has become a priority at Siemens Medical Solutions. The decision is a consequence of Siemens’ -- and other vendors’ -- success in CT.
Developing computer-aided detection for lung and colon images has become a priority at Siemens Medical Solutions. The decision is a consequence of Siemens' - and other vendors' - success in CT.
"We are flooding radiologists with all the images coming off our machines," said Joe Camaratta, vice president of global solutions for the U.S. "Siemens is investing a lot of time looking into how to make radiologists' jobs easier in reading them."
The firm released its first CAD product three years ago, syngo LungCare CT NEV (nodule-enhanced viewing), which is in use at about 500 sites worldwide, according to Siemens. A year later, the company introduced a similar product called syngo Colonography PEV (polyp-enhanced viewing).
The products emphasize identification and localization, but the future in both lung scanning and colonography will be in more ambitious developments.
"We have been looking at how CAD might help differentiate malignant from nonmalignant lesions," Camaratta said.
The company has been working with sites running its PEV and NEV products and collecting lung and colonography cases. The data are being analyzed to address a single basic question.
"Can we do more than just detect lesions?" he asked.
Engineers have been edging both PEV and NEV toward an answer. The software already automates the comparison of subsequent exams, identifying changes in the size, location, or appearance of nodules and polyps over time.
"Physicians can easily see any changes that appear in patients coming back for regular virtual colonographies," he said.
If these products keep evolving, Siemens may be able to highlight the kinds of changes radiologists need to know when making differential diagnoses.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.